Tomer Berkovitz
Director/Board Member at SOPHIA GENETICS SA
Tomer Berkovitz active positions
Companies | Position | Start | End |
---|---|---|---|
SOPHIA GENETICS SA | Director/Board Member | 01/03/2021 | - |
Independent Dir/Board Member | 01/03/2021 | - | |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Director of Finance/CFO | 01/02/2018 | - |
Private Equity Investor | 01/02/2018 | - | |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Director/Board Member | 15/09/2020 | - |
Zebra Medical Vision Ltd.
Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel. | Director/Board Member | 30/05/2018 | - |
Career history of Tomer Berkovitz
Former positions of Tomer Berkovitz
Companies | Position | Start | End |
---|---|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Chief Operating Officer | 01/05/2014 | 01/01/2018 |
Director of Finance/CFO | 01/05/2014 | 01/01/2018 | |
aMoon Fund
aMoon Fund Investment ManagersFinance aMoon Fund invests in companies located in Israel. The fund target companies operating in the fields of health tech & life sciences. It provides financing for early and later stage capital requirements with an investment size USD 10 million to 30 million. | Corporate Officer/Principal | 01/01/2014 | - |
MAPI PHARMA LTD | Director/Board Member | - | - |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance JPMorgan Chase Bank, NA provides commercial banking services. It offers investment banking, merchant services, and institutional asset management services. The company is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Training of Tomer Berkovitz
Columbia Business School | Doctorate Degree |
Tel-Aviv University | Graduate Degree |
Statistics
International
Israel | 7 |
United States | 4 |
Switzerland | 2 |
Operational
Director/Board Member | 4 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Finance | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SOPHIA GENETICS SA | Technology Services |
Private companies | 7 |
---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance JPMorgan Chase Bank, NA provides commercial banking services. It offers investment banking, merchant services, and institutional asset management services. The company is headquartered in New York, NY. | Finance |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel. | Finance |
Mapi-Pharma Ltd.
Mapi-Pharma Ltd. Pharmaceuticals: MajorHealth Technology Mapi-Pharma Ltd. is a clinical stage pharmaceutical company engaging in the development of extended-release versions of existing commercial generic drugs. Its products include injections for treatment of multiple sclerosis, active pharmaceutical ingredient, and oral drugs for the treatment of neuropathic pain. The company was founded by Ehud Marom in 2008 and is headquartered in Ness Ziona, Israel. | Health Technology |
PrognomIQ, Inc.
PrognomIQ, Inc. Medical SpecialtiesHealth Technology PrognomIQ, Inc. operates as a healthcare company, which engages in the development and commercialization of multi-omics human tests for cancer and other complex diseases. It aims to leverage Seer’s Proteograph in addition to genomics and metabolomics technologies, to develop multi-omics products to improve human health. The company is headquartered in Redwood City, CA. | Health Technology |
Zebra Medical Vision Ltd.
Zebra Medical Vision Ltd. Packaged SoftwareTechnology Services Zebra Medical Vision Ltd. engages in the development of medical imaging insights platform. The firm's solution enables researchers to develop imaging algorithms and insights based on large scale datasets and advanced processing power. The company was founded by Eyal Toledano, Eyal Gura, and Elad Benjamin in 2014 and is headquartered in Shfayim, Israel. | Technology Services |
aMoon Fund
aMoon Fund Investment ManagersFinance aMoon Fund invests in companies located in Israel. The fund target companies operating in the fields of health tech & life sciences. It provides financing for early and later stage capital requirements with an investment size USD 10 million to 30 million. | Finance |
- Stock Market
- Insiders
- Tomer Berkovitz
- Experience